Corvus Pharmaceuticals (CRVS) Non-Current Assets (2015 - 2026)

Corvus Pharmaceuticals' Non-Current Assets history runs 12 years deep, the most recent figure standing at $798000.0 for Q1 2026.

• In Q1 2026, Non-Current Assets fell 34.0% year-over-year to $798000.0; the TTM figure through Mar 2026 stood at $798000.0 (down 34.0% YoY), while the FY2025 annual figure was $904000.0, down 31.31% from the prior year.
• Non-Current Assets was $798000.0 for Q1 2026 at Corvus Pharmaceuticals, down from $904000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.8 million in Q1 2022 to a low of $798000.0 in Q1 2026.
• Historically, Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.3 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Non-Current Assets jumped 12728.57% in 2022, then slumped 34.0% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $1.7 million in 2022, then fell by 13.62% to $1.4 million in 2023, then slipped by 7.78% to $1.3 million in 2024, then tumbled by 31.31% to $904000.0 in 2025, then slipped by 11.73% to $798000.0 in 2026.
• The last three Non-Current Assets figures came in at $798000.0 (Q1 2026), $904000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.